Are Stem Cells FDA-approved

About 432,000 results

Open links in new tab

Any time

fda.gov
https://www.fda.gov › news-events › press-announcements › fda-approv…
FDA Approves First Mesenchymal Stromal Cell Therapy to Treat …
Dec 18, 2024 · FDA approves Ryoncil, the first mesenchymal stromal cell (MSC) therapy for treatment of steroid-refractory acute graft-versus-host disease (SR-a GVHD) in pediatric patients 2 months of age and older.
fda.gov
https://www.fda.gov › news-events › press-announcements › fda-approv…
FDA Approves Cell Therapy for Patients with Blood Cancers to …
Stem cell transplantation is a common treatment for blood cancers. It involves putting healthy stem cells into the body to help restore the normal production and function of blood cells.
fda.gov
https://www.fda.gov › vaccines-blood-biologics › consumers-biologics › ...
Consumer Alert on Regenerative Medicine Products Including …
Apr 9, 2024 · Stem cell products are regulated by FDA, and, generally, all stem cell products require FDA approval. Currently, the only stem cell products that are FDA-approved for use in the United States ...
fda.gov
https://www.fda.gov › ... › approved-cellular-and-gene-therapy-products
Approved Cellular and Gene Therapy Products | FDA
Nov 21, 2024 · Listing of licensed and approved products from the Office of Therapeutic Products (OTP).
fda.gov
https://www.fda.gov › news-events › press-announcements › fda-approv…
FDA Approves First Gene Therapies to Treat Patients with Sickle …
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
fda.gov
https://www.fda.gov › news-events › press-announcements › fda-approv…
FDA approves first treatment for rare disease in patients who …
This is the first FDA-approved therapy for treatment of severe hepatic VOD, a rare and life-threatening liver condition. HSCT is a procedure performed in some patients to treat certain blood or ...
fda.gov
https://www.fda.gov › news-events › press-announcements › statement-f…
Statement from FDA Commissioner Scott Gottlieb, M.D. on the …
FDA warns US Stem Cell Clinic of significant deviations; FDA acts to remove unproven, potentially harmful treatment used in a stem cellâ centers targeting vulnerable patients
fda.gov
https://www.fda.gov › news-events › press-announcements › fda-sends...
FDA sends warning to company for marketing dangerous …
The U.S. Food and Drug Administration has warned Genetech, Inc. of San Diego, California and its president, Edwin N. Pinos for marketing stem cell products without FDA approval and for significant ...
fda.gov
https://www.fda.gov › news-events › press-announcements › fda-puts...
FDA puts company on notice for marketing unapproved stem cell …
The products offered by R3 Stem Cell, LLC are not approved by the FDA. The FDA has notified each of R3 Stem Cell, LLC’s more than 50 affiliate centers or clinics of this action.
fda.gov
https://www.fda.gov › news-events › press-announcements › fda-warns-…
FDA warns US Stem Cell Clinic of significant deviations
The FDA has not reviewed or approved any biological products manufactured by US Stem Cell Clinic for any use.
Pagination
- 1
- 2
- 3
- 4